Cargando…

Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021

The aim of this review is to update the current status of allogeneic hemopoietic stem cell transplants (HSCT) for patients with myelofibrosis (MF). We have first summarized the issue of an indication for allogeneic HSCT, discussing several prognostic scoring systems, developed to predict the outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacigalupo, Andrea, Innocenti, Idanna, Rossi, Elena, Sora, Federica, Galli, Eugenio, Autore, Francesco, Metafuni, Elisabetta, Chiusolo, Patrizia, Giammarco, Sabrina, Laurenti, Luca, Benintende, Giulia, Sica, Simona, De Stefano, Valerio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129535/ https://www.ncbi.nlm.nih.gov/pubmed/34017327 http://dx.doi.org/10.3389/fimmu.2021.637512

Ejemplares similares

Predicting the outcome for patients with myelofibrosis undergoing an allogeneic hemopoietic stem cell transplant
por: Sora, Federica, et al.
Publicado: (2022)

Is Allogeneic Transplantation an Option in Patients Affected by Concurrent Myelofibrosis and Chronic Myeloid Leukemia (CML)?
por: Sora, Federica, et al.
Publicado: (2021)

Hemorrhagic cystitis in allogeneic stem cell transplantation: a role for age and prostatic hyperplasia
por: Galli, Eugenio, et al.
Publicado: (2022)

Days Alive Outside Hospital and Readmissions in Patients Undergoing Allogeneic Transplants from Identical Siblings or Alternative Donors
por: Sora, Federica, et al.
Publicado: (2020)

Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience
por: Autore, Francesco, et al.
Publicado: (2021)

Allogeneic Hematopoietic Stem Cell Transplantation In Therapy-Related Myeloid Neoplasms (t-MN) of the Adult: Monocentric Observational Study and Review of the Literature
por: Metafuni, Elisabetta, et al.
Publicado: (2018)

P1305: NEPA VERSUS ONDANSETRON FOR THE PREVENTION OF CINV IN PATIENTS WITH MULTIPLE MYELOMA OR LYMPHOMA UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. A MONOCENTRIC REAL-LIFE EXPERIENCE.
por: Innocenti, Idanna, et al.
Publicado: (2023)

Extending Long Term Follow up of Patient with Acute Myeloid Leukemia after Autologous Stem Cell Transplantation: Disclosing Late Mortality and Causes of Death
por: Sora, F., et al.
Publicado: (2020)

Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation
por: Chiusolo, Patrizia, et al.
Publicado: (2022)

H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016
por: Metafuni, Elisabetta, et al.
Publicado: (2017)

Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Massive Pulmonary Embolism at the Onset of Acute Promyelocytic Leukemia
por: Sorà, Federica, et al.
Publicado: (2016)

VEGF and IL-6 Correlation in POEMS: a Potential Upcoming Marker of Active Disease and Early Autologous BMT Response
por: Tomasso, Annamaria, et al.
Publicado: (2022)

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting
por: Metafuni, Elisabetta, et al.
Publicado: (2023)

Immunogenicity of SARS-CoV-2 vaccination in patients undergoing autologous stem cell transplantation. A multicentric experience
por: Autore, Francesco, et al.
Publicado: (2022)

Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All-Trans Retinoic Acid: A Monocentric Experience
por: Autore, Francesco, et al.
Publicado: (2023)

Impact of Covid 19 pandemic on hematopoietic stem cell transplantation activities: Report from a single center
por: Giammarco, Sabrina, et al.
Publicado: (2023)

Allogeneic Transplantation for Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2010)

Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients
por: Chiusolo, Patrizia, et al.
Publicado: (2022)

SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation
por: Sorà, Federica, et al.
Publicado: (2020)

PB1933: TREATMENT SEQUENCING AND OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED AT FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS: A THIRTY-YEAR SINGLE-CENTER EXPERIENCE.
por: Fresa, Alberto, et al.
Publicado: (2023)

New developments in the management of chronic lymphocytic leukemia: role of ofatumumab
por: Laurenti, Luca, et al.
Publicado: (2016)

Clinical and molecular features of familial chronic lymphocytic leukemia: a pilot monocentric study
por: Benintende, Giulia, et al.
Publicado: (2022)

Foscarnet treatment of cytomegalovirus infection in haploidentical or unrelated donor transplants
por: Metafuni, Elisabetta, et al.
Publicado: (2018)

Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML
por: Metafuni, Elisabetta, et al.
Publicado: (2022)

Measurable residual disease in chronic lymphocytic leukemia
por: Benintende, Giulia, et al.
Publicado: (2023)

Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review
por: Fresa, Alberto, et al.
Publicado: (2021)

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
por: Metafuni, Elisabetta, et al.
Publicado: (2022)

Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
por: Autore, Francesco, et al.
Publicado: (2021)

P1353: EFFICACY OF SARSCOV2 VACCINATION IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION. A MULTICENTER EXPERIENCE
por: Stirparo, L., et al.
Publicado: (2022)

Epstein-Barr Virus Related Lymphoproliferations After Stem Cell Transplantation
por: Sica, Simona, et al.
Publicado: (2009)

The Use of Monoclonal Antibodies in the Treatment of Autoimmune Complications of Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2013)

Chronic Lymphocytic Leukaemia: Census of Patients Treated in Italian Haematology Units
por: Salvi, Gianfranco, et al.
Publicado: (2015)

2021 Update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management
por: Ali, Haris, et al.
Publicado: (2021)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
por: Galli, Eugenio, et al.
Publicado: (2021)

PB1872: ANTIBODY RESPONSES AFTER COVID-19 VACCINATION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA, EITHER TREATED OR NAÏVE. A MONOCENTRIC EXPERIENCE.
por: Innocenti, I., et al.
Publicado: (2022)

Chronic Myeloid Leukemia in a Patient with Previous Idiopathic Thrombocytopenic Purpura: How to Manage Imatinib Together with Eltrombopag
por: Autore, Francesco, et al.
Publicado: (2021)

Immune Response to Covid-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia (CLL): An Experience from Two Italian Centres
por: Innocenti, Idanna, et al.
Publicado: (2022)

Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations
por: Riezzo, Irene, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eatuv9n8cnfmhlq2h7qg0q78ls